FDA Adverse Event Malfunction Summary report: N

ARCHITECT I2000SR ANALYZER

MDR report key: 1803123 · Received August 17, 2010

Report

Report Number
1628664-2010-00291
Event Type
Malfunction
Date Received
August 17, 2010
Date of Event
June 17, 2010
Report Date
July 27, 2010
Manufacturer
ABBOTT MANUFACTURING, INC.
Product Code
JJE
PMA / PMN Number
K983212
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). RESULTS: PROBABLE CAUSES COULD HAVE BEEN DUE TO IMPROPER LOADING OF SAMPLES ON THE INSTRUMENT AND NOT REPLACING THE SAMPLE PROBE IN THE REQUIRED TIMEFRAME. THE SAMPLE PROBE WAS LATER REPLACED ON (B)(6) 2010. REVIEW OF THE MESSAGE HISTORY SHOWED NUMEROUS SAMPLE PIPETTOR ERRORS AT THE TIME OF THE FALSE POSITIVE. THE CUSTOMER REPORTS FEWER ERRORS ARE OCCURRING SINCE REPLACING THE SAMPLE PROBE. THE CUSTOMER SUPPORT SPECIALIST ADVISED THE CUSTOMER THAT SAMPLE TUBES MUST BE PROPERLY CENTRIFUGED AND CHECKED BEFORE LOADING ONTO THE INSTRUMENT. FOLLOW UP REPRODUCIBILITY TESTING WAS ACCEPTABLE. THE CURRENT COMBINED ERRATIC RESULT RATE OF 4.48 OCCURRENCES PER MILLION TESTS FOR ARCHITECT IMMUNOASSAY INSTRUMENTS FALLS BELOW THE ESTABLISHED INTERNAL ABERRANT RESULT RATE FOR I2000SR OF 78 OCCURRENCES PER MILLION TESTS ESTABLISHED AT PRODUCT LAUNCH. NO ADVERSE TRENDS WERE IDENTIFIED RELATED TO THE ISSUE. NO OTHER COMPLAINTS WERE FOUND FOR ERRATIC COMPLAINTS ON THIS INSTRUMENT. THE ARCHITECT SYSTEM OPERATIONS MANUAL LISTS THE PROBABLE CAUSES AND CORRECTIVE ACTIONS FOR ERRATIC RESULTS AND PROVIDES INSTRUCTIONS FOR THE PROPER LOADING OF SAMPLES ON THE INSTRUMENT AND REPLACING THE SAMPLE PROBE. BASED ON THE AVAILABLE INFORMATION, A DEFICIENCY OF THE SYSTEM WAS NOT IDENTIFIED.

Additional Manufacturer Narrative · 1

(B)(4). AN INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE.

Description of Event or Problem · 1

THE ACCOUNT STATED THAT THE ARCHITECT I2000SR ANALYZER HAS GENERATED A FALSE POSITIVE TOXOPLASMOSIS IGG RESULT ON A PATIENT SAMPLE. THE INITIAL RESULT WAS POSITIVE AT 67.6 IU/ML. A SECOND SAMPLE WAS TESTED AND THE RESULT WAS NEGATIVE AT 0.1 IU/ML. THE INITIAL SAMPLE WAS THEN RETESTED AND THE RESULT WAS NEGATIVE AT 0.1 IU/ML. THERE WAS NO ADVERSE IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT I2000SR ANALYZER AUTOMATED IMMUNOASSAY ANALYZER JJE ABBOTT MANUFACTURING, INC.

Patients

Seq Age Sex Outcome Treatment
1 TOXOPLASMOSIS REAGENT: LIST 6C19-25, LOT 87859HN00| TOXOPLASMOSIS IGG RGT: L/N 6C19-25, LOT 87859HN00